Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

clinical trial

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00396279

P6099clinical trial phasephase II clinical trialQ42824440
P582end time2008-04-07
P2899minimum age18
P1132number of participants37
P4844research intervention(5R)-24,25-Dihydroxyvitamin DQ27161510
calcium oxalateQ412399
P580start time2006-07-10
P8363study typeinterventional studyQ78089383
P1476titleAn Open-Label, Multi-Center, Phase 2 Safety and Efficacy Study of Denosumab (AMG 162) in Subjects With Recurrent or Unresectable Giant Cell Tumor (GCT) of Bone